Ascending dose‐controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Obesity
DOI: 10.1002/oby.20356
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1911089380
